Grindex has announced changes in the Management Board. Sergejs Batalins has resigned as a Member of the Management Board effective October 12. Batalins' place on the Management Board will be taken by Ibraim Muhtsi who until now served as the board chairman of one of Grindex subsidiaries, Tallinn Pharmaceutical Plant.

Previously, Muhtsi had also worked at Grindex as the Director of Sales. In his career, Muhtsi has also worked as a medical practitioner, as well as he has run the department of Anaesthesiology and Intensive Care at Viru Central Hospital (Estonia). Juris Bundulis, the Board Chairman, and Chief Finance and Administrative Officer Vadims Rabsha continue working in the Management Board of Grindex.